Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinbei Rukang Pian
- Development stage
- Phase 2
- Lead developer
- Huahong Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jinbei Rukang Pian is a Chinese patent medicine (CPM) developed and manufactured by Guangxi Zhuang Autonomous Region Huahong Pharmaceutical Co., Ltd. It is specifically indicated for the treatment of breast hyperplasia (also known as fibrocystic breast changes or mastopathy). The formulation is based on Traditional Chinese Medicine (TCM) principles, designed to clear heat, resolve phlegm, and dissipate nodules. Its primary therapeutic goals are to alleviate breast pain (mastalgia) and reduce the size of glandular lumps associated with hyperplastic mammary tissue. The product contains a blend of herbal ingredients, including *Fritillaria thunbergii*, *Taraxacum*, and *Prunella vulgaris*, which are believed to exert anti-inflammatory and regulatory effects on the breast tissue environment. It is administered orally in tablet form.
- Brand names
- Jinbei Rukang Pian
- Other names
- Jinbei Rukang Tablets
02
Targets
AKT (RAC-alpha serine/threonine-protein kinase)IL-6 (Interleukin 6)JNK (Mitogen-activated protein kinase kinase kinase family)MAPK14 (p38 mitogen-activated protein kinase alpha)
Beyond the preview
Go deeper on Jinbei Rukang Pian.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jinbei Rukang Pian.